---
title: "STAAR SURGICAL CO (STAA) stock: news and investor profile"
url: "https://aibio.space/companies/staar-surgical/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "STAAR SURGICAL CO (NASDAQ: STAA), United States. Listing facts, related biotech companies and news on aibio.space."
---

STAA STAAR SURGICAL CO NASDAQ · United States

# STAAR SURGICAL CO (STAA) news

STAAR SURGICAL CO is a public biotech or pharmaceutical company listed on NASDAQ under the ticker STAA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest STAAR SURGICAL CO news

We have not published a story on STAAR SURGICAL CO yet. When there is news, it will appear here.

## STAAR SURGICAL CO at a glance

- **Ticker**: STAA

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Jul 3, 2026**: $181.5 million

### Related companies

- [ZIMMER BIOMET HOLDINGS, INC.](https://aibio.space/companies/zimmer-biomet/) NYSE: ZBH
- [QIAGEN](https://aibio.space/companies/qiagen-n-v/) NYSE: QGEN
- [Electromedical Technologies](https://aibio.space/companies/electromedical-technologies/) OTC: EMED
- [INTEGRA LIFESCIENCES HOLDINGS CORP](https://aibio.space/companies/integra-lifesciences/) NASDAQ: IART
- [Vivos Therapeutics](https://aibio.space/companies/vivos-therapeutics/) NASDAQ: VVOS
- [Virax Biolabs Group](https://aibio.space/companies/virax-biolabs/) NASDAQ: VRAX
- [InspireMD](https://aibio.space/companies/inspiremd/) NASDAQ: NSPR
- [Twist Bioscience](https://aibio.space/companies/twist-bioscience/) NASDAQ: TWST

### Also on NASDAQ

- [ILLUMINA, INC.](https://aibio.space/companies/illumina/) ILMN
- [Harrow](https://aibio.space/companies/harrow/) HROW
- [Amneal Pharmaceuticals](https://aibio.space/companies/amneal-pharmaceuticals/) AMRX
- [IDEAYA Biosciences](https://aibio.space/companies/ideaya-biosciences/) IDYA
- [Inogen](https://aibio.space/companies/inogen/) INGN
- [TREACE MEDICAL CONCEPTS, INC.](https://aibio.space/companies/treace-medical-concepts/) TMCI

## STAAR SURGICAL CO annual financials

| Line | FY ended Jan 2, 2026 | FY ended Dec 27, 2024 |
|---|---|---|
| Revenue | [$239.4 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) | [$313.9 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) |
| Research and development | [$40.1 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) | [$45.3 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) |
| Net income (loss) | [-$80.4 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) | [-$20.2 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) |
| Cash from operations | [-$34.2 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) | [$15.7 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) |
| Cash and equivalents | [$153.2 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000037/) | [$144.2 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) |
| Short-term investments | [$34.4 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000037/) | [$86.3 million](https://www.sec.gov/Archives/edgar/data/718937/000071893726000004/) |

Latest balance sheet, Jul 3, 2026 (10-Q): cash and equivalents $148.6 million, plus short-term investments of $32.9 million, $181.5 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about STAAR SURGICAL CO

What is the ticker symbol of STAAR SURGICAL CO?

STAAR SURGICAL CO trades under the ticker STAA on NASDAQ.

Where is STAAR SURGICAL CO listed?

STAAR SURGICAL CO is listed on NASDAQ.

Which country or territory is STAAR SURGICAL CO listed under?

Our directory records STAAR SURGICAL CO under United States.

Does aibio.space cover STAAR SURGICAL CO?

aibio.space lists STAAR SURGICAL CO among 2,820 public biotech companies and publishes its news here as stories appear.

What was STAAR SURGICAL CO's revenue last year?

$239.4 million for the fiscal year ended Jan 2, 2026, as reported to the SEC.

Is STAAR SURGICAL CO profitable?

STAAR SURGICAL CO reported a net loss of $80.4 million for the fiscal year ended Jan 2, 2026, and used $34.2 million of cash in operations, per its annual report to the SEC.

How much does STAAR SURGICAL CO spend on research and development?

$40.1 million in the fiscal year ended Jan 2, 2026, per its annual report.

How much cash does STAAR SURGICAL CO have?

$181.5 million in cash and short-term investments at Jul 3, 2026, per its 10-Q.

## Investor discussion: STAAR SURGICAL CO

Members talk about STAAR SURGICAL CO (STAA). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:STAA on TradingView](https://www.tradingview.com/symbols/NASDAQ-STAA/).

## Listing details

STAAR SURGICAL CO is a public biotech or pharmaceutical company listed on NASDAQ under the ticker STAA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: STAAR SURGICAL CO

- **Ticker**: STAA

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/staar-surgical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "STAAR SURGICAL CO (STAA) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/staar-surgical/
